Medical oncologists provide comprehensive insights on neoadjuvant therapy options for patients with melanoma.
Health Professionals
Hispanic Men With Melanoma Have Reduced Survival, Disease-Specific Disparities
Hispanic men with cutaneous melanoma receive melanoma diagnoses at an older age, show advanced-stage disease, present with melanoma of the trunk rather than lower extremities, and have reduced disease-specific survival when compared with Hispanic women with melanoma, according to study results published in Skin Health and Disease.
TCR CDR3s and renalase-1 linked to increased melanoma survival
BUFFALO, NY- August 8, 2024 – A new research paper was published in Oncotarget’s Volume 15 on August 5, 2024, entitled, “Chemical complementarity of tumor resident, T-cell receptor CDR3s and renalase-1 correlates with increased melanoma survival.”
Melanoma: predicting immunotherapy-induced side effects
Scientists at NYU Langone Health and its Perlmutter Cancer Center have revealed that an activity pattern in genes that build spleen tyrosine kinases can predict which melanoma patients are likely to have severe side effects from immunotherapy.